Fall Series Session 3: Cancer, Equity, and Global Access

About the ACMG Fall 2026 Seminar Series

Wednesdays, October 7, November 4, and December 2 | 11:00 am ET – 12:30 pm ET
Total 4.5 AMA PRA Category 1 Credits™ and P.A.C.E.®
Credit Claiming by December 31, 2026

Genomic medicine is advancing at an unprecedented pace, transforming how we diagnose, treat, and care for patients. The ACMG Fall 2026 Seminar Series brings together leading experts across three virtual sessions to explore the latest developments in therapeutics, diagnostics, and equitable access to genomic medicine. Designed for medical geneticists, laboratory geneticists, genetic counselors, trainees, and the broader genetics team, the series extends timely education between ACMG Annual Clinical Genetics Meetings.

December 2, 2026 – Session 3: Cancer, Equity, and Global Access

This session addresses where genomic care still falls short and how to close the gap. Presentations share implementation insights on integrated cancer genomic risk assessment and strategies for delivering genomic testing to rare-disease families in low- and middle-income settings, with an additional presentation to be announced.